Drug Approval | October 05, 2023
Alembic received 6 USFDA approvals during Q2FY24
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
The Government of India continues to prioritise initiatives aimed at enhancing the accessibility and equity of health services
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
Subscribe To Our Newsletter & Stay Updated
